Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jonas Schnittert, M. Heinrich, Praneeth Kuninty, G. Storm, J. Prakash (2018)
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer.Cancer letters, 420
B. Ruffell, Debbie Chang-Strachan, Vivien Chan, Alexander Rosenbusch, Alexander Rosenbusch, Christine Ho, N. Pryer, D. Daniel, E. Hwang, H. Rugo, L. Coussens (2014)
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.Cancer cell, 26 5
G Bender, EE Schexnaydre, RC Murphy, C Uhlson, ME Newcomer (2016)
Membrane-dependent activities of human 15-LOX-2 and its murine counterpart: implications for murine models of atherosclerosisThe Journal of Biological Chemistry, 291
H. Ogasawara, S. Ishii, T. Yokomizo, T. Kakinuma, M. Komine, K. Tamaki, Takao Shimizu, T. Izumi (2002)
Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2The Journal of Biological Chemistry, 277
Xiangsheng Zuo, Yuanqing Wu, J. Morris, J. Stimmel, L. Leesnitzer, Susan Fischer, Scott Lippman, I. Shureiqi (2006)
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activityOncogene, 25
V. Prima, L. Kaliberova, S. Kaliberov, D. Curiel, S. Kusmartsev (2017)
COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cellsProceedings of the National Academy of Sciences, 114
J. Poczobutt, S. De, V. Yadav, Teresa Nguyen, Howard Li, Trisha Sippel, M. Weiser-Evans, R. Nemenoff (2016)
Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung CancerThe Journal of Immunology, 196
K. Hooper, J. Yen, Weimin Kong, Kate Rahbari, Ping-chang Kuo, A. Gamero, D. Ganea (2017)
Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1The Journal of Immunology, 198
T. Kochel, A. Fulton (2015)
Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.Prostaglandins & other lipid mediators, 116-117
Irina Daurkin, E. Eruslanov, Taryn Stoffs, G. Perrin, C. Algood, S. Gilbert, C. Rosser, L. Su, J. Vieweg, S. Kusmartsev (2011)
Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway.Cancer research, 71 20
S. Uderhardt, M. Herrmann, O. Oskolkova, S. Aschermann, W. Bicker, N. Ipseiz, K. Sarter, B. Frey, T. Rothe, R. Voll, F. Nimmerjahn, V. Bochkov, G. Schett, G. Krönke (2011)
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic toleranceJournal of Translational Medicine, 9
C. Heise, B. O'dowd, D. Figueroa, N. Sawyer, Tuan Nguyen, D. Im, R. Stocco, J. Bellefeuille, M. Abramovitz, R. Cheng, David Williams, Z. Zeng, Qingyun Liu, Lei Ma, M. Clements, N. Coulombe, Yuan Liu, Christopher Austin, S. George, G. O'neill, K. Metters, K. Lynch, Jilly Evans (2000)
Characterization of the Human Cysteinyl Leukotriene 2 Receptor*The Journal of Biological Chemistry, 275
M. Yarchoan, Burles Johnson, Eric Lutz, D. Laheru, E. Jaffee (2017)
Targeting neoantigens to augment antitumour immunityNature Reviews Cancer, 17
Lu Gan, Zhu Qiu, Jing Huang, Yunhai Li, Hongyan Huang, T. Xiang, J. Wan, Tianli Hui, Y. Lin, Hongzhong Li, G. Ren (2016)
Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathwayInternational Journal of Biological Sciences, 12
Xinzhi Li, Ying-li Yu, C. Funk (2013)
Cyclooxygenase‐2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4)The FASEB Journal, 27
M. Moussalli, Yuanqing Wu, Xiangsheng Zuo, Xiu Yang, I. Wistuba, M. Raso, Jeffrey Morris, J. Bowser, J. Minna, R. Lotan, I. Shureiqi (2011)
Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation EvasionCancer Prevention Research, 4
Z. Wen, Hainan Liu, M. Li, B. Li, W. Gao, Q. Shao, B. Fan, F. Zhao, Qin Wang, Q. Xie, Yongmei Yang, Jun Yu, Xun Qu (2014)
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltrationOncogene, 34
M. Sulciner, C. Serhan, Molly Gilligan, Dayna Mudge, Jaimie Chang, A. Gartung, Kristen Lehner, D. Bielenberg, Birgitta Schmidt, J. Dalli, Emily Greene, Yael Gus‐Brautbar, Julia Piwowarski, T. Mammoto, D. Zurakowski, M. Perretti, V. Sukhatme, A. Kaipainen, M. Kieran, Sui Huang, D. Panigrahy (2018)
Resolvins suppress tumor growth and enhance cancer therapyThe Journal of Experimental Medicine, 215
S. Biswas, A. Mantovani (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigmNature Immunology, 11
A. Sampey, S. Monrad, L. Crofford (2005)
Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2Arthritis Research & Therapy, 7
Eva Overmeire, B. Stijlemans, F. Heymann, J. Keirsse, Yannick Morias, Y. Elkrim, L. Brys, C. Abels, Qods Lahmar, Can Ergen, Lars Vereecke, Frank Tacke, P. Baetselier, J. Ginderachter, Damya Laoui (2016)
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.Cancer research, 76 1
Jie Liang, M. Nagahashi, Eugene Kim, K. Harikumar, A. Yamada, Wei‐Ching Huang, N. Hait, J. Allegood, Megan Price, D. Avni, K. Takabe, T. Kordula, S. Milstien, S. Spiegel (2013)
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.Cancer cell, 23 1
Sophia Wuest, M. Crucet, Claudio Gemperle, C. Loretz, M. Hersberger (2012)
Expression and regulation of 12/15-lipoxygenases in human primary macrophages.Atherosclerosis, 225 1
M. Cannarile, M. Weisser, W. Jacob, A. Jegg, Carola Ries, D. Rüttinger (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapyJournal for Immunotherapy of Cancer, 5
C. Gregory, M. Paterson (2017)
An apoptosis-driven ‘onco-regenerative niche’: roles of tumour-associated macrophages and extracellular vesiclesPhilosophical Transactions of the Royal Society B: Biological Sciences, 373
J. Shen, W. Li, Z. Xiao, L. Zhang, M. Li, L. Li, W. Hu, L. Lu, F. Boudreau, C. Cho (2016)
The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons.Current medicinal chemistry, 23 11
M. Kiss, S. Gassen, K. Movahedi, Y. Saeys, Damya Laoui (2018)
Myeloid cell heterogeneity in cancer: not a single cell alike.Cellular immunology, 330
K. Lötzer, C. Funk, A. Habenicht (2005)
The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.Biochimica et biophysica acta, 1736 1
Anna Alexanian, A. Sorokin (2017)
Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.Physiological genomics, 49 11
T. Kitamura, Binzhi Qian, D. Soong, Luca Cassetta, R. Noy, Gaël Sugano, Yu Kato, Jiu-feng Li, J. Pollard (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophagesThe Journal of Experimental Medicine, 212
E. Eruslanov, S. Kaliberov, Irina Daurkin, L. Kaliberova, D. Buchsbaum, J. Vieweg, S. Kusmartsev (2009)
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in CancerThe Journal of Immunology, 182
M. Edelman, D. Watson, Xiaofei Wang, C. Morrison, R. Kratzke, S. Jewell, L. Hodgson, A. Mauer, A. Gajra, G. Masters, M. Bedor, E. Vokes, Mark Green (2008)
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 6
N. Chabane, N. Zayed, M. Benderdour, J. Martel-Pelletier, J. Pelletier, N. Duval, H. Fahmi (2009)
Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritisArthritis Research & Therapy, 11
C. Schneider, A. Pozzi (2011)
Cyclooxygenases and lipoxygenases in cancerCancer and Metastasis Reviews, 30
W. Powell, J. Rokach (2015)
Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.Biochimica et biophysica acta, 1851 4
Felix Klug, H. Prakash, P. Huber, T. Seibel, N. Bender, N. Halama, C. Pfirschke, Ralf-Holger Voss, C. Timke, L. Umansky, Kay Klapproth, K. Schäkel, N. Garbi, D. Jäger, J. Weitz, H. Schmitz‐Winnenthal, G. Hämmerling, P. Beckhove (2013)
Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.Cancer cell, 24 5
P. Nandi, G. Girish, Mousumi Majumder, X. Xin, E. Tutunea-Fatan, P. Lala (2017)
PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cellsBMC Cancer, 17
Sivalokanathan Sarveswaran, N. Varma, Shravan Morisetty, J. Ghosh (2016)
Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.Oncotarget
A. Gentles, Aaron Newman, C. Liu, S. Bratman, Weiguo Feng, Dongkyoon Kim, V. Nair, Yue Xu, Amanda Khuong, Chuong Hoang, M. Diehn, R. West, S. Plevritis, Ash Alizadeh (2015)
Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancersCancer Research, 75
Manuel Díaz-Muñoz, Inés Osma-García, M. Fresno, M. Íñiguez (2012)
Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages.The Biochemical journal, 443 2
B. Ruffell, Nesrine Affara, L. Coussens (2012)
Differential macrophage programming in the tumor microenvironment.Trends in immunology, 33 3
R. Hammamieh, Dena Sumaida, Xiaoyan Zhang, R. Das, M. Jett (2007)
Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolismBMC Cancer, 7
A. Weigert, A. Knethen, D. Fuhrmann, N. Dehne, B. Brüne (2018)
Redox-signals and macrophage biology.Molecular aspects of medicine, 63
Xuesong Qian, Jidong Zhang, Jianguo Liu (2010)
Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway*The Journal of Biological Chemistry, 286
Yu Zhu, J. Herndon, Dorothy Sojka, Ki-Wook Kim, Brett Knolhoff, Chong Zuo, D. Cullinan, Jingqin Luo, Audrey Bearden, K. Lavine, W. Yokoyama, W. Hawkins, R. Fields, G. Randolph, D. DeNardo (2017)
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.Immunity, 47 3
C. Abrial, S. Grassin-Delyle, H. Salvator, M. Brollo, E. Naline, P. Devillier (2015)
15‐Lipoxygenases regulate the production of chemokines in human lung macrophagesBritish Journal of Pharmacology, 172
M. Seo, D. Oh (2017)
Prostaglandin synthases: Molecular characterization and involvement in prostaglandin biosynthesis.Progress in lipid research, 66
Carola Ries, M. Cannarile, S. Hoves, J. Benz, K. Wartha, V. Runza, Flora Rey-Giraud, Leon Pradel, F. Feuerhake, I. Klaman, T. Jones, U. Jucknischke, Stefan Scheiblich, K. Kaluza, Ingo Gorr, A. Walz, K. Abiraj, P. Cassier, A. Sica, C. Gomez-Roca, K. Visser, A. Italiano, C. Tourneau, J. Delord, H. Levitsky, J. Blay, D. Rüttinger (2014)
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.Cancer cell, 25 6
A. Weigert, S. Schiffmann, Divya Sekar, S. Ley, Heidi Menrad, C. Werno, Sabine Grosch, G. Geisslinger, B. Brüne (2009)
Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti‐inflammatory phenotypeInternational Journal of Cancer, 125
A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, P. Allavena (2017)
Tumour-associated macrophages as treatment targets in oncologyNature Reviews Clinical Oncology, 14
V. O’Donnell, R. Murphy (2012)
New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.Blood, 120 10
Z. Zaslona, E. Palsson-McDermott, Deepthi Menon, M. Haneklaus, E. Flis, Hannah Prendeville, Sarah Corcoran, M. Peters-Golden, L. O’Neill (2017)
The Induction of Pro–IL-1β by Lipopolysaccharide Requires Endogenous Prostaglandin E2 ProductionThe Journal of Immunology, 198
Meera Rath, I. Müller, P. Kropf, E. Closs, M. Munder (2014)
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in MacrophagesFrontiers in Immunology, 5
E. Gounaris, Michael Heiferman, J. Heiferman, Manisha Shrivastav, Dominic Vitello, N. Blatner, L. Knab, J. Phillips, E. Cheon, P. Grippo, K. Khazaie, H. Munshi, D. Bentrem (2015)
Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic InflammationPLoS ONE, 10
R. Franklin, W. Liao, A. Sarkar, Myoungjoo Kim, Michael Bivona, Kang Liu, E. Pamer, Ming Li (2014)
The cellular and molecular origin of tumor-associated macrophagesScience, 344
M. Tong, Yunfei Ding, H. Tai (2006)
Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.Carcinogenesis, 27 11
V. Hammond, V. O’Donnell (2012)
Esterified eicosanoids: generation, characterization and function.Biochimica et biophysica acta, 1818 10
D. Madsen, H. Jürgensen, M. Siersbæk, D. Kuczek, Loretta Cloud, Shihui Liu, N. Behrendt, Lars Grøntved, R. Weigert, T. Bugge (2017)
Tumor-Associated Macrophages Derived from Circulating Inflammatory Monocytes Degrade Collagen through Cellular Uptake.Cell reports, 21 13
Rui Tian, Xiangsheng Zuo, Jonathan Jaoude, F. Mao, Jennifer Colby, I. Shureiqi (2017)
ALOX15 as a suppressor of inflammation and cancer: Lost in the link.Prostaglandins & other lipid mediators, 132
Camilla Engblom, C. Pfirschke, M. Pittet (2016)
The role of myeloid cells in cancer therapiesNature Reviews Cancer, 16
I Ivanov, H Kuhn, HD Structural (2015)
functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15)Gene, 573
T. Yokomizo, Kazuhiko Kato, H. Hagiya, T. Izumi, Takao Shimizu (2001)
Hydroxyeicosanoids Bind to and Activate the Low Affinity Leukotriene B4 Receptor, BLT2*The Journal of Biological Chemistry, 276
G. Moore, G. Pidgeon (2017)
Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase PathwayInternational Journal of Molecular Sciences, 18
Xiaoming Rong, Bo Huang, Shu-wei Qiu, Xiang-pen Li, Lei He, Ying Peng (2016)
Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activationOncotarget, 7
S. Reinartz, Tim Schumann, F. Finkernagel, A. Wortmann, Julia Jansen, W. Meissner, M. Krause, A. Schwörer, U. Wagner, S. Müller-Brüsselbach, R. Müller (2013)
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapseInternational Journal of Cancer. Journal International du Cancer, 134
A. Klil-Drori, A. Ariel (2013)
15-Lipoxygenases in cancer: a double-edged sword?Prostaglandins & other lipid mediators, 106
J. Poczobutt, Teresa Nguyen, Dwight Hanson, Howard Li, Trisha Sippel, M. Weiser-Evans, M. Gijon, R. Murphy, R. Nemenoff (2016)
Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell RecruitmentThe Journal of Immunology, 196
G. Pidgeon, M. Kandouz, Anthony Meram, K. Honn (2002)
Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.Cancer research, 62 9
Seokwoo Park, D. Heo, M. Sung (2012)
The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cellsCellular Oncology, 35
C. Gregory, J. Pound (2011)
Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissuesThe Journal of Pathology, 223
V. Chiurchiù, A. Leuti, M. Maccarrone (2018)
Bioactive Lipids and Chronic Inflammation: Managing the Fire WithinFrontiers in Immunology, 9
(2009)
5-Lipoxygenase: mechanisms of regulation.
Curtis Perry, A. Muñoz-Rojas, Katrina Meeth, Laura Kellman, R. Amezquita, D. Thakral, Victor Du, J. Wang, W. Damsky, Alexandra Kuhlmann, Joel Sher, M. Bosenberg, K. Miller-Jensen, S. Kaech (2018)
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunityThe Journal of Experimental Medicine, 215
K. Khan, Poonam Kothari, B. Du, A. Dannenberg, D. Falcone (2012)
Matrix Metalloproteinase-Dependent Microsomal Prostaglandin E Synthase-1 Expression in Macrophages: Role of TNF-α and the EP4 Prostanoid ReceptorThe Journal of Immunology, 188
Amira Barkal, K. Weiskopf, Kevin Kao, S. Gordon, B. Rosental, Y. Yiu, B. George, Maxim Markovic, N. Ring, Jonathan Tsai, K. McKenna, P. Ho, Robin Cheng, J. Chen, Layla Barkal, A. Ring, I. Weissman, R. Maute (2017)
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyNature Immunology, 19
V. Barresi, M. Grosso, E. Vitarelli, G. Tuccari, G. Barresi (2007)
5-Lipoxygenase is Coexpressed with Cox-2 in Sporadic Colorectal Cancer: A Correlation with Advanced StageDiseases of the Colon & Rectum, 50
D. Xia, Dingzhi Wang, Sun-Hee Kim, R. Dubois (2011)
Abstract 89: Prostaglandin E2 promotes intestinal tumor growth via DNA methylationCancer Research, 71
J. Bystrom, I. Evans, Justine Newson, Melanie Stables, I. Toor, N. Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, D. Gilroy (2008)
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMPBlood, 112
Qi Zhang, B. Zhu, Yongsheng Li (2017)
Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer TherapyFrontiers in Immunology, 8
Xiang Zheng, Kati Turkowski, Javier Mora, B. Brüne, W. Seeger, A. Weigert, R. Savai (2017)
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapyOncotarget, 8
M. Nagahashi, A. Yamada, Eriko Katsuta, T. Aoyagi, Wei‐Ching Huang, Krista Terracina, N. Hait, J. Allegood, Junko Tsuchida, K. Yuza, Masato Nakajima, M. Abe, K. Sakimura, S. Milstien, T. Wakai, S. Spiegel, K. Takabe (2018)
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.Cancer research, 78 7
A. Koeberle, O. Werz (2015)
Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.Biochemical pharmacology, 98 1
Vinit Kumar, Laxminarasimha Donthireddy, D. Marvel, T. Condamine, F. Wang, Sergio Lavilla-Alonso, A. Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee Goins, Charles Mulligan, Brian Nam, N. Hockstein, F. Denstman, Shanti Shakamuri, D. Speicher, A. Weeraratna, Timothy Chao, R. Vonderheide, L. Languino, P. Ordentlich, Qin Liu, Xiaowei Xu, Albert Lo, E. Puré, Chunsheng Zhang, Andrey Loboda, Manuel Sepulveda, L. Snyder, D. Gabrilovich (2017)
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.Cancer cell, 32 5
A. Rossi, C. Pergola, A. Koeberle, M. Hoffmann, Friederike Dehm, P. Bramanti, S. Cuzzocrea, O. Werz, L. Sautebin (2010)
The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophagesBritish Journal of Pharmacology, 161
E. Cheon, M. Strouch, S. Krantz, Michael Heiferman, D. Bentrem (2012)
Genetic Deletion of 5-Lipoxygenase Increases Tumor-Infiltrating Macrophages in ApcΔ468 MiceJournal of Gastrointestinal Surgery, 16
K. Arima, Y. Komohara, L. Bu, M. Tsukamoto, R. Itoyama, K. Miyake, Tomoyuki Uchihara, Y. Ogata, S. Nakagawa, H. Okabe, K. Imai, D. Hashimoto, A. Chikamoto, Y. Yamashita, H. Baba, T. Ishimoto (2018)
Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancerCancer Science, 109
Lei Xiao, M. Ornatowska, Guiqing Zhao, H. Cao, Rui Yu, Jing Deng, Yongchao Li, Qiong Zhao, R. Sadikot, J. Christman (2012)
Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived MacrophagesPLoS ONE, 7
G. O’Callaghan, A. Houston (2015)
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?British Journal of Pharmacology, 172
C. Serhan, Chia Nan, J. Dalli, B. Levy (2015)
Lipid mediators in the resolution of inflammation.Cold Spring Harbor perspectives in biology, 7 2
E. Eruslanov, Irina Daurkin, J. Ortiz, J. Vieweg, S. Kusmartsev (2010)
Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cellsJournal of Leukocyte Biology, 88
F. Balkwill, M. Capasso, T. Hagemann (2012)
The tumor microenvironment at a glanceJournal of Cell Science, 125
W. Lim, C. June (2017)
The Principles of Engineering Immune Cells to Treat CancerCell, 168
A. Morgan, V. Hammond, Machiko Sakoh-Nakatogawa, Y. Ohsumi, Christopher Thomas, Fabien Blanchet, V. Piguet, K. Kiselyov, V. O’Donnell (2014)
A novel role for 12/15-lipoxygenase in regulating autophagyRedox Biology, 4
E. Müller, P. Christopoulos, S. Halder, A. Lunde, K. Beraki, Martin Speth, I. Øynebråten, A. Corthay (2017)
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 MacrophagesFrontiers in Immunology, 8
P. Boger, J. Shutt, J. Neale, S. Wilson, A. Bateman, J. Holloway, P. Patel, A. Sampson (2012)
Increased expression of the 5‐lipoxygenase pathway and its cellular localization in Barrett’s adenocarcinomaHistopathology, 61
W. Sha, B. Brüne, A. Weigert (2012)
The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.Immunobiology, 217 12
Takuto Nosaka, T. Baba, Yamato Tanabe, Soichiro Sasaki, Tatsunori Nishimura, Y. Imamura, Hideaki Yurino, S. Hashimoto, M. Arita, Y. Nakamoto, N. Mukaida (2018)
Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4The Journal of Immunology, 200
M. Nagahashi, A. Yamada, T. Aoyagi, W.-C. Huang, Krista Terracina, N. Hait, J. Allegood, Junko Tsuchida, Masato Nakajima, Eriko Katsuta, S. Milstien, T. Wakai, S. Spiegel, K. Takabe (2018)
Abstract P1-01-06: Targeting the SphK1/S1P/S1PR1 axis that connects obesity, chronic inflammation, and breast cancer metastasisCancer Research, 78
Binzhi Qian, Jiu-feng Li, Hui Zhang, T. Kitamura, Jinghang Zhang, Liam Campion, E. Kaiser, L. Snyder, J. Pollard (2011)
CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasisNature, 475
Yonit Lavin, Soma Kobayashi, A. Leader, E. Amir, Naama Elefant, C. Bigenwald, R. Remark, Robert Sweeney, C. Becker, Jacob Levine, K. Meinhof, A. Chow, Seunghee Kim-Shulze, A. Wolf, C. Medaglia, Hanjie Li, J. Rytlewski, R. Emerson, Alexander Solovyov, B. Greenbaum, C. Sanders, M. Vignali, M. Beasley, R. Flores, S. Gnjatic, D. Pe’er, Adeeb Rahman, I. Amit, M. Merad (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell AnalysesCell, 169
Yang Ou, Shang-Jui Wang, Dawei Li, Bo Chu, W. Gu (2016)
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responsesProceedings of the National Academy of Sciences, 113
Sivalokanathan Sarveswaran, D. Chakraborty, D. Chitale, R. Sears, J. Ghosh (2014)
Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells*The Journal of Biological Chemistry, 290
Naresh Kumar, G. Gupta, K. Anilkumar, Naireen Fatima, Roy Karnati, G. Reddy, P. Giri, P. Reddanna (2016)
15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasomeScientific Reports, 6
J. Moreno (2009)
New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development.Biochemical pharmacology, 77 1
P. Tymoszuk, H. Evens, Vanessa Marzola, Katarzyna Wachowicz, Marie‐Helene Wasmer, S. Datta, E. Müller-Holzner, H. Fiegl, G. Böck, N. Rooijen, I. Theurl, W. Doppler (2014)
In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumorsEuropean Journal of Immunology, 44
D. Kuang, Qiyi Zhao, C. Peng, Jing Xu, Jing-Ping Zhang, Changyou Wu, Limin Zheng (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1The Journal of Experimental Medicine, 206
Reiko Ikegami, Y. Sugimoto, E. Segi, M. Katsuyama, H. Karahashi, F. Amano, T. Maruyama, Hana Yamane, Soken Tsuchiya, A. Ichikawa (2001)
The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages1The Journal of Immunology, 166
Xiangsheng Zuo, Zhanglong Peng, Yuanqing Wu, M. Moussalli, Xiu Yang, Yan Wang, J. Parker-Thornburg, Jeffrey Morris, R. Broaddus, S. Fischer, I. Shureiqi (2012)
Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.Journal of the National Cancer Institute, 104 9
C. Brenner, L. Galluzzi, O. Kepp, G. Kroemer (2013)
Decoding cell death signals in liver inflammation.Journal of hepatology, 59 3
Woosung Chung, Hye Eum, Hae-Ock Lee, Kyung-min Lee, Han-Byoel Lee, Kyu‐Tae Kim, H. Ryu, Sangmin Kim, J. Lee, Yeon-Hee Park, Zhengyan Kan, W. Han, W. Park (2017)
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancerNature Communications, 8
J. Poczobutt, M. Gijon, Jay Amin, Dwight Hanson, Howard Li, Deandra Walker, M. Weiser-Evans, Xian Lu, R. Murphy, R. Nemenoff (2013)
Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the MicroenvironmentPLoS ONE, 8
S. Willingham, J. Volkmer, A. Gentles, D. Sahoo, P. Dalerba, S. Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Justin Cohen, Patricia Lovelace, F. Scheeren, M. Chao, K. Weiskopf, Chad Tang, A. Volkmer, T. Naik, Theresa Storm, Adriane Mosley, Badreddin Edris, S. Schmid, C. Sun, M. Chua, O. Murillo, Pradeep Rajendran, Adriel Cha, R. Chin, Dongkyoon Kim, M. Adorno, T. Raveh, D. Tseng, S. Jaiswal, P. Enger, G. Steinberg, Gordon Li, S. So, R. Majeti, G. Harsh, M. Rijn, N. Teng, J. Sunwoo, Ash Alizadeh, M. Clarke, I. Weissman (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 109
V. Marcheselli, Song‐Pyo Hong, W. Lukiw, Xiaolin Tian, K. Gronert, A. Musto, M. Hardy, J. Giménez, Chia Nan, C. Serhan, N. Bazan (2003)
Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression*Journal of Biological Chemistry, 278
S. Biswas (2015)
Metabolic Reprogramming of Immune Cells in Cancer Progression.Immunity, 43 3
S. Dahlén (2006)
Treatment of asthma with antileukotrienes: first line or last resort therapy?European journal of pharmacology, 533 1-3
Dingzhi Wang, R. Dubois (2010)
Eicosanoids and cancerNature Reviews Cancer, 10
M. Matsuyama, T. Hayama, K. Funao, Y. Kawahito, H. Sano, Y. Takemoto, T. Nakatani, R. Yoshimura (2007)
Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.Oncology reports, 18 1
V. Kagan, G. Mao, F. Qu, J. Angeli, S. Doll, C. Croix, H. Dar, B. Liu, V. Tyurin, V. Ritov, A. Kapralov, A. Amoscato, Jianfei Jiang, T. Anthonymuthu, D. Mohammadyani, Qin Yang, B. Proneth, J. Klein-Seetharaman, Simon Watkins, I. Bahar, J. Greenberger, R. Mallampalli, B. Stockwell, Y. Tyurina, M. Conrad, H. Bayır (2017)
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.Nature chemical biology, 13 1
R. Franklin, Ming Li (2016)
Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation.Trends in cancer, 2 1
Julia Ringleb, E. Strack, C. Angioni, G. Geisslinger, D. Steinhilber, A. Weigert, B. Brüne (2018)
Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated MacrophagesThe Journal of Immunology, 200
M. Peters-Golden (2009)
Putting on the Brakes: Cyclic AMP as a Multipronged Controller of Macrophage FunctionScience Signaling, 2
J. Ghosh, C. Myers (1998)
Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.Proceedings of the National Academy of Sciences of the United States of America, 95 22
Catherine Olesch, W. Sha, C. Angioni, L. Sha, Elias Açaf, P. Patrignani, P. Jakobsson, H. Radeke, S. Grösch, G. Geisslinger, A. Knethen, A. Weigert, B. Brüne (2015)
MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancerOncotarget, 6
H. Kamata, K. Hosono, Tatsunori Suzuki, Yasufumi Ogawa, Hidefumi Kubo, H. Katoh, Yoshiya Ito, S. Uematsu, S. Akira, M. Watanabe, M. Majima (2010)
mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 64 6
Damya Laoui, K. Movahedi, Eva Overmeire, J. Bossche, E. Schouppe, C. Mommer, Alexandros Nikolaou, Yannick Morias, P. Baetselier, J. Ginderachter (2011)
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.The International journal of developmental biology, 55 7-9
D. Ruffell, F. Mourkioti, A. Gambardella, Peggy Kirstetter, R. Lopez, N. Rosenthal, C. Nerlov (2009)
A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repairProceedings of the National Academy of Sciences, 106
N. Janakiram, Altaf Mohammed, Taylor Bryant, Rebekah Ritchie, Nicole Stratton, L. Jackson, S. Lightfoot, D. Benbrook, A. Asch, M. Lang, C. Rao (2017)
Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ miceImmunology, 152
K. Larsson, P. Jakobsson (2015)
Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.Prostaglandins & other lipid mediators, 120
A. Weigert, Javier Mora, Divya Sekar, S. Syed, B. Brüne (2016)
Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression.Advances in experimental medicine and biology, 930
P. Kalinski (2012)
Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 188
S. Lee, C. Serezani, A. Medeiros, M. Ballinger, M. Peters-Golden (2009)
Crosstalk between Prostaglandin E2 and Leukotriene B4 Regulates Phagocytosis in Alveolar Macrophages via Combinatorial Effects on Cyclic AMP1The Journal of Immunology, 182
T. Nywening, B. Belt, D. Cullinan, R. Panni, B. Han, D. Sanford, Ryan Jacobs, Jian Ye, Ankit Patel, W. Gillanders, R. Fields, D. DeNardo, W. Hawkins, P. Goedegebuure, D. Linehan (2017)
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinomaGut, 67
S. Reinartz, F. Finkernagel, Till Adhikary, Verena Rohnalter, Tim Schumann, Y. Schober, W. Nockher, Andrea Nist, T. Stiewe, Julia Jansen, U. Wagner, S. Müller-Brüsselbach, R. Müller (2016)
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcomeGenome Biology, 17
N. Dehne, Javier Mora, D. Namgaladze, A. Weigert, B. Brüne (2017)
Cancer cell and macrophage cross‐talk in the tumor microenvironmentCurrent Opinion in Pharmacology, 35
Jochen Ackermann, K. Hofheinz, M. Zaiss, G. Krönke (2017)
The double-edged role of 12/15-lipoxygenase during inflammation and immunity.Biochimica et biophysica acta. Molecular and cell biology of lipids, 1862 4
A. Johann, A. Weigert, W. Eberhardt, Anne-Marie Kuhn, Vera Barra, A. Knethen, J. Pfeilschifter, B. Brüne (2008)
Apoptotic Cell-Derived Sphingosine-1-Phosphate Promotes HuR-Dependent Cyclooxygenase-2 mRNA Stabilization and Protein Expression1The Journal of Immunology, 180
H. Kwon, S-N Kim, Y.A. Kim, Y.-H. Lee (2016)
The contribution of arachidonate 15-lipoxygenase in tissue macrophages to adipose tissue remodelingCell Death & Disease, 7
S. Hangai, Tomoka Ao, Y. Kimura, Kosuke Matsuki, T. Kawamura, Hideo Negishi, J. Nishio, T. Kodama, T. Taniguchi, H. Yanai (2016)
PGE2 induced in and released by dying cells functions as an inhibitory DAMPProceedings of the National Academy of Sciences, 113
D Xia, D Wang, S-H Kim, H Katoh, RN Dubois (2012)
Prostaglandin E2 promotes intestinal tumor growth via DNA methylationNature Medicine, 18
Stéphane Chevrier, Jacob Levine, Vito Zanotelli, K. Silina, D. Schulz, M. Bacac, Carola Ries, L. Ailles, M. Jewett, H. Moch, M. Broek, C. Beisel, Michael Stadler, C. Gedye, Bernhard Reis, D. Pe’er, B. Bodenmiller (2017)
An Immune Atlas of Clear Cell Renal Cell CarcinomaCell, 169
E. Tran, P. Robbins, S. Rosenberg (2017)
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutationsNature Immunology, 18
B. Luan, Young-sil Yoon, John Lay, K. Kaestner, S. Hedrick, M. Montminy (2015)
CREB pathway links PGE2 signaling with macrophage polarizationProceedings of the National Academy of Sciences, 112
I. Ivanov, H. Kuhn, D. Heydeck (2015)
Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15).Gene, 573 1
S. Zelenay, Annemarthe Veen, Jan Böttcher, Kathryn Snelgrove, N. Rogers, S. Acton, P. Chakravarty, M. Girotti, R. Marais, S. Quezada, E. Sahai, C. Sousa (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of ImmunityCell, 162
K. Brecht, A. Weigert, Jiong Hu, R. Popp, B. Fisslthaler, T. Korff, I. Fleming, G. Geisslinger, B. Brüne (2011)
Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2The FASEB Journal, 25
Benjamin Weichand, R. Popp, Sarah Dziumbla, Javier Mora, E. Strack, Eiman Elwakeel, Ann-Christin Frank, K. Scholich, Sandra Pierre, S. Syed, Catherine Olesch, Julia Ringleb, Bilge Ören, C. Döring, R. Savai, M. Jung, A. Knethen, B. Levkau, I. Fleming, A. Weigert, B. Brüne (2017)
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1βThe Journal of Experimental Medicine, 214
M. Sokolowska, Li-yuan Chen, Yueqin Liu, A. Martínez‐Antón, H. Qi, C. Logun, S. Alsaaty, Y. Park, D. Kastner, J. Chae, J. Shelhamer (2015)
Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human MacrophagesThe Journal of Immunology, 194
K. Movahedi, Damya Laoui, C. Gysemans, M. Baeten, G. Stangé, J. Bossche, M. Mack, D. Pipeleers, P. Veld, P. Baetselier, J. Ginderachter (2010)
Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.Cancer research, 70 14
M. Palma, D. Biziato, T. Petrova (2017)
Microenvironmental regulation of tumour angiogenesisNature Reviews Cancer, 17
V. Fadok, D. Bratton, A. Konowal, Peter Freed, J. Westcott, P. Henson (1998)
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.The Journal of clinical investigation, 101 4
T. Curiel, G. Coukos, L. Zou, Xavier Alvarez, P. Cheng, P. Mottram, Melina Evdemon-Hogan, J. Conejo-Garcia, Lin Zhang, M. Burow, Yun Zhu, Shuang Wei, Ilona Kryczek, B. Daniel, Alan Gordon, L. Myers, A. Lackner, M. Disis, K. Knutson, Lieping Chen, W. Zou (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 10
Takuji Tanaka, H. Kohno, S. Yoshitani, S. Takashima, A. Okumura, Akira Murakami, M. Hosokawa (2001)
Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.Cancer research, 61 6
S. Gordon, R. Maute, Ben Dulken, G. Hutter, B. George, M. Mccracken, Rohit Gupta, Jonathan Tsai, Rahul Sinha, Daniel Corey, A. Ring, A. Connolly, I. Weissman (2017)
PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunityNature, 545
Ole Helm, J. Held-Feindt, E. Grage‐Griebenow, N. Reiling, H. Ungefroren, I. Vogel, U. Krüger, T. Becker, M. Ebsen, C. Röcken, D. Kabelitz, H. Schäfer, S. Sebens (2014)
Tumor‐associated macrophages exhibit pro‐ and anti‐inflammatory properties by which they impact on pancreatic tumorigenesisInternational Journal of Cancer, 135
K. Kang, T. Ling, Horng-Huei Liou, Yong-Kang Huang, M. Hour, Horng-Chi Liou, W. Fu (2013)
Enhancement role of host 12/15-lipoxygenase in melanoma progression.European journal of cancer, 49 12
A. Deguchi, Steven Xing, I. Shureiqi, Peiying Yang, R. Newman, S. Lippman, S. Feinmark, B. Oehlen, I. Weinstein (2005)
Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.Cancer research, 65 18
H. Pham, Tinku Banerjee, V. Ziboh (2004)
Suppression of cyclooxygenase‐2 overexpression by 15S‐hydroxyeicosatrienoic acid in androgen‐dependent prostatic adenocarcinoma cellsInternational Journal of Cancer, 111
W. Fridman, L. Zitvogel, C. Sautès-Fridman, G. Kroemer (2017)
The immune contexture in cancer prognosis and treatmentNature Reviews Clinical Oncology, 14
M. Nakatsuji, M. Minami, H. Seno, M. Yasui, H. Komekado, Sei Higuchi, Risako Fujikawa, Y. Nakanishi, A. Fukuda, K. Kawada, Y. Sakai, T. Kita, P. Libby, H. Ikeuchi, M. Yokode, T. Chiba (2015)
EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated TumorigenesisPLoS Genetics, 11
Sagie Schif-Zuck, N. Gross, Simaan Assi, R. Rostoker, C. Serhan, A. Ariel (2011)
Saturated‐efferocytosis generates pro‐resolving CD11blow macrophages: Modulation by resolvins and glucocorticoidsEuropean Journal of Immunology, 41
AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancersNature Medicine, 21
Z. Zaslona, C. Serezani, Katsuhide Okunishi, D. Aronoff, M. Peters-Golden (2012)
Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling.Blood, 119 10
Ying Feng, Xiangyang Bai, Qiuhui Yang, Hong Wu, Dian Wang (2010)
Downregulation of 15-lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells.International journal of oncology, 36 6
S. Hoves, C. Ooi, Carsten Wolter, H. Sade, Stefan Bissinger, Martina Schmittnaegel, O. Ast, A. Giusti, K. Wartha, V. Runza, W. Xu, Y. Kienast, M. Cannarile, H. Levitsky, S. Romagnoli, Michele Palma, D. Rüttinger, Carola Ries (2018)
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunityThe Journal of Experimental Medicine, 215
F. Mao, Min Xu, Xiangsheng Zuo, Jiang Yu, Weiguo Xu, M. Moussalli, Elias Elias, Haiyan Li, S. Watowich, I. Shureiqi (2015)
15‐Lipoxygenase‐1 suppression of colitis‐associated colon cancer through inhibition of the IL‐6/STAT3 signaling pathwayThe FASEB Journal, 29
H Ogasawara, S Ishii, T Yokomizo, T Kakinuma, M Komine, K Tamaki (2002)
Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distributionThe Journal of Biological Chemistry, 277
R. Wu, Zhixiong Huang, Jing Ran, Songjuan Dai, Dianchao Lin, Tai-Wei Ng, Qing-Xi Chen, Qionghua Chen (2018)
Lipoxin A4 Suppresses Estrogen-Induced Epithelial–Mesenchymal Transition via ALXR-Dependent Manner in EndometriosisReproductive Sciences, 25
H. Kuhn, Swathi Banthiya, K. Leyen (2015)
Mammalian lipoxygenases and their biological relevance.Biochimica et biophysica acta, 1851 4
A. Mantovani, P. Allavena, A. Sica, F. Balkwill (2008)
Cancer-related inflammationNature, 454
Z. Meng, R. Cao, Zhonghua Yang, Tao Liu, Yongzhi Wang, Xinghuan Wang (2013)
Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.Urology, 82 6
Güneş Bender, Erin Schexnaydre, R. Murphy, Charis Uhlson, M. Newcomer (2016)
Membrane-dependent Activities of Human 15-LOX-2 and Its Murine CounterpartThe Journal of Biological Chemistry, 291
T. Yokomizo, Kazuhiko Kato, K. Terawaki, Takashi Izumi, Takao Shimizu (2000)
A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.The Journal of experimental medicine, 192 3
T. Cooks, I. Pateras, L. Jenkins, K. Patel, A. Robles, J. Morris, T. Forshew, E. Appella, V. Gorgoulis, C. Harris (2018)
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246Nature Communications, 9
I. Shureiqi, Wei Jiang, Xiangsheng Zuo, Yuanqing Wu, J. Stimmel, L. Leesnitzer, Jeffrey Morris, Huilian Fan, S. Fischer, S. Lippman (2003)
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cellsProceedings of the National Academy of Sciences of the United States of America, 100
C. Su, X. Wen, S. Bailey, Wen Jiang, S. Rangwala, S. Keilbaugh, A. Flanigan, S. Murthy, M. Lazar, Gary Wu (1999)
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.The Journal of clinical investigation, 104 4
E. Chen, E. Smyth (2011)
COX-2 and PGE2-dependent immunomodulation in breast cancer.Prostaglandins & other lipid mediators, 96 1-4
Yang Liu, Xuetao Cao (2016)
Characteristics and Significance of the Pre-metastatic Niche.Cancer cell, 30 5
M. Cavnar, S. Zeng, Teresa Kim, Eric Sorenson, L. Ocuin, V. Balachandran, A. Seifert, Jonathan Greer, Rachel Popow, Megan Crawley, N. Cohen, B. Green, F. Rossi, P. Besmer, C. Antonescu, R. DeMatteo (2013)
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationThe Journal of Experimental Medicine, 210
Yuka Sasaki, D. Kamei, Y. Ishikawa, T. Ishii, S. Uematsu, Shizuo Akira, Makoto Murakami, Shuntaro Hara (2012)
Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesisOncogene, 31
A Weigert, J Mora, D Sekar, S Syed, B Brüne, I Killing (2016)
Not enough: how apoptosis hijacks tumor-associated macrophages to promote cancer progressionAdvances in Experimental Medicine and Biology, 930
The tumor immune landscape gained considerable interest based on the knowledge that genetic aberrations in cancer cells alone are insufficient for tumor development. Macrophages are basically supporting all hallmarks of cancer and owing to their tremendous plasticity they may exert a whole spectrum of anti-tumor and pro-tumor activities. As part of the innate immune response, macrophages are armed to attack tumor cells, alone or in concert with distinct T cell subsets. However, in the tumor microenvironment, they sense nutrient and oxygen gradients, receive multiple signals, and respond to this incoming information with a phenotype shift. Often, their functional output repertoire is shifted to become tumor-supportive. Incoming and outgoing signals are chemically heterogeneous but also comprise lipid mediators. Here, we review the current understanding whereby arachidonate metabolites derived from the cyclooxygenase and lipoxygenase pathways shape the macrophage phenotype in a tumor setting. We discuss these findings in the context of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1) expression and concomitant prostaglandin E2 (PGE2) formation. We elaborate the multiple actions of this lipid in affecting macrophage biology, which are sensors for and generators of this lipid. Moreover, we summarize properties of 5-lipoxygenases (ALOX5) and 15-lipoxygenases (ALOX15, ALOX15B) in macrophages and clarify how these enzymes add to the role of macrophages in a dynamically changing tumor environment. This review will illustrate the potential routes how COX-2/mPGES-1 and ALOX5/-15 in macrophages contribute to the development and progression of a tumor.
Cancer and Metastasis Reviews – Springer Journals
Published: May 28, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.